Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Paraproteinemias 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia 1

Interventions

Cyclophosphamide 172Rituximab 161Specimen Handling 115Biopsy 92Magnetic Resonance Spectroscopy 90Vincristine 88Doxorubicin 82Prednisone 80fludarabine 71venetoclax 70obinutuzumab 63Lenalidomide 56ibrutinib 55Dexamethasone 55Cytarabine 49Methotrexate 47acalabrutinib 43Etoposide 43CT-P10 41blinatumomab 38fludarabine phosphate 35Bendamustine Hydrochloride 35Gemcitabine 33prednylidene 32zanubrutinib 31deltacortene 31pembrolizumab 30Calcium Dobesilate 30glofitamab 29Nivolumab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chromatin Immunoprecipitation Sequencing × Lymphoid × 90 days × Clear all
NCT06870760 2026-04-16

Pre-malignant States to Hematologic Malignancies in Firefighters

Wake Forest University Health Sciences

Recruiting
300 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Paraproteinemias, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡